Ctgf as target for the therapy of diabetic nephropathy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/39 (2006.01) A61K 31/00 (2006.01) A61K 38/00 (2006.01) A61K 39/395 (2006.01) A61P 13/12 (2006.01)

Patent

CA 2555789

The present invention relates to methods and compounds for treating specific early stage aspects and late stage aspects of diabetic nephropathy. Methods and compounds for treating various physiological features associated with early stage and with late stage diabetic nephropathy are also provided.

La présente invention concerne des procédés et des composés destinés au traitement de la néphropathie diabétique à l'état précoce ou avancé. L'invention concerne également des procédés et composés destinés au traitement de diverses caractéristiques physiologiques associées à la néphropathie diabétique à l'état précoce ou avancé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Ctgf as target for the therapy of diabetic nephropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ctgf as target for the therapy of diabetic nephropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ctgf as target for the therapy of diabetic nephropathy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1544255

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.